NO971341L - Promoter for reseptor tyrosinkinase TIE - Google Patents

Promoter for reseptor tyrosinkinase TIE

Info

Publication number
NO971341L
NO971341L NO971341A NO971341A NO971341L NO 971341 L NO971341 L NO 971341L NO 971341 A NO971341 A NO 971341A NO 971341 A NO971341 A NO 971341A NO 971341 L NO971341 L NO 971341L
Authority
NO
Norway
Prior art keywords
tyrosine kinase
receptor tyrosine
promoter
kinase tie
tie
Prior art date
Application number
NO971341A
Other languages
English (en)
Other versions
NO971341D0 (no
Inventor
Kari Alitalo
Original Assignee
Univ Helsinki Licensing
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Helsinki Licensing filed Critical Univ Helsinki Licensing
Publication of NO971341D0 publication Critical patent/NO971341D0/no
Publication of NO971341L publication Critical patent/NO971341L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Promotersekvensen for Tie, en endothelial celleresptor tyrosin kinase og anvendelse i terapi og diagnostikk samt produksjon av proteiner i blod og vev er beskrevet.
NO971341A 1994-09-22 1997-03-21 Promoter for reseptor tyrosinkinase TIE NO971341L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31071794A 1994-09-22 1994-09-22
PCT/FI1995/000520 WO1996009381A1 (en) 1994-09-22 1995-09-22 Promoter for the receptor tyrosine kinase, tie

Publications (2)

Publication Number Publication Date
NO971341D0 NO971341D0 (no) 1997-03-21
NO971341L true NO971341L (no) 1997-05-14

Family

ID=23203808

Family Applications (1)

Application Number Title Priority Date Filing Date
NO971341A NO971341L (no) 1994-09-22 1997-03-21 Promoter for reseptor tyrosinkinase TIE

Country Status (8)

Country Link
US (1) US5877020A (no)
EP (1) EP0783572B1 (no)
JP (1) JPH10506011A (no)
AT (1) ATE294236T1 (no)
AU (1) AU701568B2 (no)
DE (1) DE69534180T2 (no)
NO (1) NO971341L (no)
WO (1) WO1996009381A1 (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2756570B1 (fr) * 1996-12-03 2002-09-27 Commissariat Energie Atomique Promoteur de la ve-cadherine et ses utilisations
US5972338A (en) 1997-09-19 1999-10-26 Genentech, Inc. Tie ligands homologues
US6350450B1 (en) 1997-09-19 2002-02-26 Genentech, Inc. TIE ligand homologue antibody
US6057435A (en) * 1997-09-19 2000-05-02 Genentech, Inc. Tie ligand homologues
US6348350B1 (en) 1997-09-19 2002-02-19 Genentech, Inc. Ligand homologues
US6030831A (en) 1997-09-19 2000-02-29 Genetech, Inc. Tie ligand homologues
US6130207A (en) * 1997-11-05 2000-10-10 South Alabama Medical Science Foundation Cell-specific molecule and method for importing DNA into a nucleus
AU2001244509A1 (en) * 2000-03-30 2001-10-08 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method of treatment of conditions involving obstruction of blood flow
WO2002044156A2 (en) * 2000-11-29 2002-06-06 Glaxo Group Limited Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors
US20090181092A1 (en) * 2004-07-16 2009-07-16 Spinal Restoration, Inc. Methods for Treating Joints and Discs with a Carrier Matrix and Cells
GB0423554D0 (en) * 2004-10-22 2004-11-24 Cancer Rec Tech Ltd Therapeutic compounds
GB0428082D0 (en) * 2004-12-22 2005-01-26 Welcome Trust The Ltd Therapeutic compounds
CA2649994A1 (en) 2006-04-26 2007-11-08 Cancer Research Technology Limited Imidazo[4,5-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2-one compounds and analogs thereof as cancer therapeutic compounds
RU2499599C2 (ru) * 2007-09-28 2013-11-27 Интрексон Корпорейшн Конструкции терапевтического переключения генов и биореакторы для экспрессии биотерапевтических молекул и их применение
US8198279B2 (en) * 2007-12-19 2012-06-12 Institute Of Cancer Research: Royal Cancer Hospital (The) Pyrido[2,3-b]pyrazin-8-substituted compounds and their use
GB0807609D0 (en) * 2008-04-25 2008-06-04 Cancer Rec Tech Ltd Therapeutic compounds and their use
BR112012018415A2 (pt) 2010-02-01 2020-08-04 Cancer Research Technology Limited composto, composição, métodos de preparar uma composição e de tratamento, e, uso de um composto.
WO2014125291A1 (en) 2013-02-14 2014-08-21 Ucl Business Plc Agents which induce lymphangiogenesis for use in the treatment of cystic kidney disease
GB201320729D0 (en) 2013-11-25 2014-01-08 Cancer Rec Tech Ltd Therapeutic compounds and their use
GB201320732D0 (en) 2013-11-25 2014-01-08 Cancer Rec Tech Ltd Methods of chemical synthesis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT69792A (en) * 1992-01-09 1995-09-28 Helsinki University Holding Lt Tie, a nocel endothelial cell receptor tyrosine kinase
US5466596A (en) * 1992-08-25 1995-11-14 Mount Sinai Hospital Corporation Tissue specific transcriptional regulatory element

Also Published As

Publication number Publication date
AU701568B2 (en) 1999-02-04
WO1996009381A1 (en) 1996-03-28
JPH10506011A (ja) 1998-06-16
NO971341D0 (no) 1997-03-21
EP0783572A1 (en) 1997-07-16
EP0783572B1 (en) 2005-04-27
US5877020A (en) 1999-03-02
ATE294236T1 (de) 2005-05-15
DE69534180D1 (de) 2005-06-02
DE69534180T2 (de) 2006-03-02
AU3474895A (en) 1996-04-09

Similar Documents

Publication Publication Date Title
NO971341L (no) Promoter for reseptor tyrosinkinase TIE
TR199901172T2 (xx) Yeni ikame edilmi� pirazol t�revleri.
ATE309360T1 (de) Vaskularer endothelialer wachstumsfaktor 2
IL127558A0 (en) Hepatocyte growth factor receptor agonists and uses thereof
BR0206985A (pt) Anticorpos modificados e métodos de uso
BR9910251A (pt) Estimulação hematopoiética
FI963070A0 (fi) Klooripyrimidiinivälituotteita
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
MXPA02002384A (es) Polipeptidos similares al factor de crecimiento de fibroblastos.
ATE368054T1 (de) Verbindungen und methoden zur modulierung von occludin-abhängiger gewebepermeabilität
DE60226499D1 (de) Verwendung von antikörpern gegen das muc18-antigen
FI960727A (fi) Neurokiniiniantagonisteina käyttökelpoiset heterosyklit
DK1007537T3 (da) Receptor-protein med betegnelsen 2F1
DE69721021D1 (de) Blasenmukosa mit zellen für die rekonstruktion von geweben
EA200100264A1 (ru) Ангиоцидин: адгезионный рецептор опухолей клетки, специфический для cys-ser-val-thr-cys-gly
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
TR200000697T2 (tr) İkame edilmiş 1,2,3,4,5,6-Heksahidro-2,6-Metano-3-Benzazosin-10-OL'ler, üretim yöntemleri ve farmasötik preparat olarak kullanımları.
NO982181L (no) Type IX collagen og chimerer
BG101126A (en) The use of muramylpeptide compounds
IT1307864B1 (it) Metodo diagnostico per il riconoscimento di neoplasie umane attraversola determinazione dell'isoforma ctn-c della tn-c, frammenti di
ES2177769T3 (es) Derivado de aminotetralina para la terapia de trastornos cardiovascu lares.
TR200000416T2 (tr) Neisseria loctoferrin bağlayıcı protein.
IS5231A (is) Vefjaþáttur sem hefur áhrif á blóðæðarmyndun
BR0012704A (pt) Anticorpos antitumor, proteìnas e usos dos mesmos
CA2200846A1 (en) Promoter for the receptor tyrosine kinase, tie

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application